Richard B. Toupence

Person

Chicago, IL, US

People

Patents Grantslast 30 patents

Information Patent Grant
Diazabicyclic central nervous system active agents
- Patent number 8,119,635
- Issue date Feb 21, 2012
- Abbott Laboratories
- Michael R. Schrimpf
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Diazabicyclic central nervous system active agents
- Patent number 7,598,236
- Issue date Oct 6, 2009
- Abbott Laboratories
- Michael R. Schrimpf
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Diazabicyclic central nervous system active agents
- Patent number 7,319,106
- Issue date Jan 15, 2008
- Abbott Laboratories
- Michael R. Schrimpf
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted 2,3-diphenyl pyridines
- Patent number 7,271,266
- Issue date Sep 18, 2007
- Merck & Co., Inc.
- Paul E. Finke
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Diazabicyclic CNS active agents
- Patent number 7,265,115
- Issue date Sep 4, 2007
- Abbott Laboratories
- William H. Bunnelle
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Azabicyclic compounds are central nervous system active agents
- Patent number 7,135,484
- Issue date Nov 14, 2006
- Abbott Laboratories
- Michael J. Dart
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted furo[2,3-b]pyridine derivatives
- Patent number 7,091,216
- Issue date Aug 15, 2006
- Merck & Co., Inc.
- Richard B. Toupence
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Diazabicyclic central nervous system active agents
- Patent number 6,809,105
- Issue date Oct 26, 2004
- Abbott Laboratories
- Michael R. Schrimpf
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antagonists of gonadotropin releasing hormone
- Patent number 6,150,352
- Issue date Nov 21, 2000
- Merck & Co., Inc.
- Mark Goulet
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzisoxazole-derived antidiabetic compounds
- Patent number 6,090,836
- Issue date Jul 18, 2000
- Merck & Co., Inc.
- Alan D. Adams
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treating diabetes and related disease states
- Patent number 6,020,382
- Issue date Feb 1, 2000
- Merck & Co., Inc.
- Thomas W. Doebber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treating diabetes and related disease states
- Patent number 5,847,008
- Issue date Dec 8, 1998
- Merck & Co., Inc.
- Thomas W. Doebber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Phenoxyphenylacetic acid derivatives
- Patent number 5,668,176
- Issue date Sep 16, 1997
- Merck & Co. Inc.
- Scott W. Bagley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Biphenyl compounds useful or endothelin antagonists
- Patent number 5,565,485
- Issue date Oct 15, 1996
- Merck & Co., Inc.
- Scott W. Bagley
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
DIAZABICYCLIC CENTRAL NERVOUS SYSTEM ACTIVE AGENTS
- Publication number 20120208820
- Publication date Aug 16, 2012
- Michael R. Schrimpf
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DIAZABICYCLIC CENTRAL NERVOUS SYSTEM ACTIVE AGENTS
- Publication number 20100016277
- Publication date Jan 21, 2010
- Abbott Laboratories
- Michael R. Schrimpf
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DIAZABICYCLIC CENTRAL NERVOUS SYSTEM ACTIVE AGENTS
- Publication number 20080097094
- Publication date Apr 24, 2008
- Abbott Laboratories
- Michael R. Schrimpf
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Azabicyclic compounds are central nervous system active agents
- Publication number 20060287290
- Publication date Dec 21, 2006
- Michael J. Dart
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted furo[2,3-b]pyridine derivatives
- Publication number 20050272763
- Publication date Dec 8, 2005
- Richard B. Toupence
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted 2,3-diphenyl pyridines
- Publication number 20050182103
- Publication date Aug 18, 2005
- Paul E Finke
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Diazabicyclic central nervous system active agents
- Publication number 20040186107
- Publication date Sep 23, 2004
- Michael R. Schrimpf
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Azabicyclic compounds are central nervous system active agents
- Publication number 20040152724
- Publication date Aug 5, 2004
- Michael J. Dart
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Azabicyclic compounds are central nervous system active agents
- Publication number 20040044029
- Publication date Mar 4, 2004
- Michael J. Dart
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Diazabicyclic CNS active agents
- Publication number 20030225268
- Publication date Dec 4, 2003
- William H. Bunnelle
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Diazabicyclic central nervous system active agents
- Publication number 20020019388
- Publication date Feb 14, 2002
- Michael R. Schrimpf
- C07 - ORGANIC CHEMISTRY

Richard B. Toupence

Person

Patents Grantslast 30 patents

Diazabicyclic central nervous system active agents

Diazabicyclic central nervous system active agents

Diazabicyclic central nervous system active agents

Substituted 2,3-diphenyl pyridines

Diazabicyclic CNS active agents

Azabicyclic compounds are central nervous system active agents

Substituted furo[2,3-b]pyridine derivatives

Diazabicyclic central nervous system active agents

Antagonists of gonadotropin releasing hormone

Benzisoxazole-derived antidiabetic compounds

Method of treating diabetes and related disease states

Method of treating diabetes and related disease states

Phenoxyphenylacetic acid derivatives

Biphenyl compounds useful or endothelin antagonists

Patents Applicationslast 30 patents

DIAZABICYCLIC CENTRAL NERVOUS SYSTEM ACTIVE AGENTS

DIAZABICYCLIC CENTRAL NERVOUS SYSTEM ACTIVE AGENTS

DIAZABICYCLIC CENTRAL NERVOUS SYSTEM ACTIVE AGENTS

Azabicyclic compounds are central nervous system active agents

Substituted furo[2,3-b]pyridine derivatives

Substituted 2,3-diphenyl pyridines

Diazabicyclic central nervous system active agents

Azabicyclic compounds are central nervous system active agents

Azabicyclic compounds are central nervous system active agents

Diazabicyclic CNS active agents

Diazabicyclic central nervous system active agents